Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms
about
Safety, Efficacy, Pharmacokinetics, Pharmacodynamics of ACZ885 in Patients With NALP3 Mutations and Clinical Symptoms
description
clinical trial
@en
klinisch onderzoek
@nl
name
Safety, Efficacy, Pharmacokine ...... utations and Clinical Symptoms
@en
type
label
Safety, Efficacy, Pharmacokine ...... utations and Clinical Symptoms
@en
prefLabel
Safety, Efficacy, Pharmacokine ...... utations and Clinical Symptoms
@en
P17
P1476
An Open-Label, Phase II Dose T ...... Patients With NALP3 Mutations
@en
P3098
NCT00487708
P580
2005-01-01T00:00:00Z
P582
2008-07-01T00:00:00Z